Takeda’s flagship GICC to create 750 jobs, foster technological innovation with emphasis on plasma-based therapy: Our Bureau, ...

Gleneagles Hospital performs Mumbai’s first domino kidney transplant of the year for sensitized patients: Our Bureau, Mumbai ...

Vivoryon Therapeutics provides R&D-update further strengthening development pipeline in kidney disease: Munich, Germany Wednesday, January 15, 2025, 18:00 Hrs [IST] Vivoryon Thera ...

Tata Group partners with IISc investing Rs. 500 crore to set-up medical school to pioneer healthcare education and research: Our Bureau, Bengaluru Wednesday, January 15, 2025, 17: ...

NIH-funded study finds cases of ME/CFS increase following SARS-CoV-2: Maryland Wednesday, January 15, 2025, 17:00 Hrs [IST] New findings from the National Institutes of Health’s ...

Illumina & NVIDIA collaborate to decode biology and propel precision health: San Diego Wednesday, January 15, 2025, 16:00 Hrs [IST] Illumina, Inc., a global leader in genomic sequ ...

Santhera gets positive recommendation from Scottish Medicines Consortium for use of Agamree to treat Duchenne muscular dystrophy: Pratteln, Switzerland Wednesday, January 15, 2025 ...

AskBio begins patient randomizing in phase II gene therapy trial for Parkinson’s disease: Berlin, Germany Wednesday, January 15, 2025, 14:00 Hrs [IST] AskBio Inc. (AskBio), a ge ...

Regeneron announces adjuvant Libtayo significantly improves DFS after surgery in high-risk CSCC in phase 3 trial: Tarrytown, New York Wednesday, January 15, 2025, 11:00 Hrs [IST] ...

BioArctic announces US FDA accepts Eisai’s BLA for subcutaneous maintenance dosing of Leqembi: Stockholm Wednesday, January 15, 2025, 13:00 Hrs [IST] BioArctic AB (publ) announc ...

Rockville, Maryland Wednesday, January 15, 2025, 12:00 Hrs [IST] ...

Our Bureau, Mumbai Wednesday, January 15, 2025, 11:30 Hrs [IST] ...